ESRRB and breast carcinoma: In other studies, the overexpression of ERRβ has been correlated with improved prognosis and longer relapse-free survival in breast cancer patients, and its mRNA levels inversely correlated with tumor cells in S-phase in patient-derived tumor samples (122).